The first case of Mpox infection in Iran during the 2022 outbreak

Authors

  • Ali Maleki COVID-19 National Reference Laboratory (CNRL), Pasteur Institute of Iran, Tehran, Iran https://orcid.org/0000-0002-6044-3052
  • Arash Arashkia Department of Influenza and Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran https://orcid.org/0000-0002-3117-3217
  • Mohammad Hassan Pouriayevali Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran https://orcid.org/0000-0003-0133-1517
  • Tahmineh Jalali Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran
  • Mahsa Tavakoli Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran
  • Mohammad Modoodi Yaghooti COVID-19 National Reference Laboratory (CNRL), Pasteur Institute of Iran, Tehran, Iran https://orcid.org/0000-0003-4577-3288
  • Zahra Ahmadi COVID-19 National Reference Laboratory (CNRL), Pasteur Institute of Iran, Tehran, Iran https://orcid.org/0000-0001-9305-3002
  • Farideh Niknam Oskouei COVID-19 National Reference Laboratory (CNRL), Pasteur Institute of Iran, Tehran, Iran
  • Zahra Fereydouni COVID-19 National Reference Laboratory (CNRL), Pasteur Institute of Iran, Tehran, Iran https://orcid.org/0000-0001-8032-6817
  • Kayhan Azadmanesh Department of Influenza and Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran
  • Mostafa Salehi‐Vaziri Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran https://orcid.org/0000-0001-8892-8505
  • Mahdi Rohani Rapid Response Team, Pasteur Institute of Iran, Tehran, Iran

DOI:

https://doi.org/10.3855/jidc.18589

Keywords:

Mpox, MPXV, Iran

Abstract

Introduction: The unexpected outbreak of human Mpox infection beginning in some European countries that were non-endemic for Mpox stunned the world during the Coronavirus Disease 2019 (COVID-19) pandemic in May 2022. The re-emerging Mpox outbreak, which has a greater capacity for human-to-human transmission, was mainly due to traveling. In this paper, we describe the first case of the disease was observed in an Iranian woman infected by her husband who had a history of traveling to Canada.

Case Report: The 34-year-old woman had flu-like syndrome with some skin rashes on her hand, finger, and arm. No antivirals were prescribed in this case, and supportive care was used to help her recover. RT-PCR and Sanger sequencing were used to analyze the sample from the oropharyngeal swab and the rash, and the results confirmed the Mpox infection.

Conclusions: The risk of infectious disease outbreaks after COVID-19, such as Mpox, is of great importance, and health systems should be vigilant for timely identification and preparedness.

Downloads

Published

2024-09-30

How to Cite

1.
Maleki A, Arashkia A, Pouriayevali MH, Jalali T, Tavakoli M, Modoodi Yaghooti M, Ahmadi Z, Niknam Oskouei F, Fereydouni Z, Azadmanesh K, Salehi‐Vaziri M, Rohani M (2024) The first case of Mpox infection in Iran during the 2022 outbreak. J Infect Dev Ctries 18:1450–1452. doi: 10.3855/jidc.18589

Issue

Vol. 18 No. 09: September 2024

Section

Case Reports

License

Copyright (c) 2024 Ali Maleki, Arash Arashkia, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Mahsa Tavakoli, Mohammad Modoodi Yaghooti, Zahra Ahmadi, Farideh Niknam Oskouei, Zahra Fereydouni, Kayhan Azadmanesh, Mostafa Salehi‐Vaziri, Mahdi Rohani

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC

Funding data